Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
British American Tobacco $2.5 billion notes offering
The offering is composed of three tranches of notes
Alkami Technology $345 million convertible senior notes offering
The 1.5% convertible notes are due 2030
First Citizens BancShares $1.25 billion notes offering
The investment-grade notes are due 2031 and 2040
Bank of America €3.25 billion senior notes offering
The investment-grade debt offering consists of two tranches
Spirit Airlines emerges from chapter 11
We advised Spirit in connection with its chapter 11 cases
Primo Brands $1.5 billion debut secondary offering
The shares are listed on the New York Stock Exchange
Beam Therapeutics $500 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Axon Enterprise $1.75 billion senior notes offering
The high-yield notes are due 2030 and 2033
Verisk $700 million senior notes offering
We advised Verisk on the SEC-registered notes
Strategy $21 billion perpetual strike preferred stock at-the-market offering
The perpetual strike preferred stock is listed on the Nasdaq Global Select Market